The CRC is a joint project of Fraunhofer ITEM, MHH and HZI. A clinical trial centre for clinical phase I studies is being established on the site of the ITEM.

This centre is the final link in the development chain of new medicines formed by TRAIN. Research findings and data from pre-clinical phases are rapidly translated to clinical research here.

The clinical trial centre will therefore bridge the gap between the development of active agents and application on the patients ‑ until now the biggest step in the development of new medicines, diagnostics and therapies.